Abbott India
Update in progressABBOTINDIA.NS (NSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Abbott India Limited and its subsidiaries operate as a pharmaceutical company in India. It offers products across gastroenterology, women’s health, metabolic and central nervous system disorders, vaccines and multispecialty care, including insomnia, vitamin D deficiency, pre-term labor and pain management. The portfolio also covers anti-infectives, cardio-metabolic, GI and hepatology, hormones, neuropsychiatry, respiratory, neuroscience, metabolics and consumer care. Formerly Knoll Pharmaceuticals, it was renamed in 2002. Founded in 1910, it is based in Mumbai and is a subsidiary of Abbott Capital India Limited.
Company score
- Sentiment
- 0.16
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.00
- Governance
- -0.03
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.01
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.08
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNSE (NSI)
- LocationIndia
- Founded1910
- Employees3,679
- Websitewww.abbott.co.in
Identifiers
- ISININE358A01014